Catalyst Pharmaceuticals, Inc. (CPRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 355 ALHAMBRA CIRCLE
CORAL GABLES, FL 33134
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments298,395191,266140,27894,51953,48284,013
Cash and cash equivalents298,395171,445130,23789,51216,55957,497
Short-term investments  19,82110,0415,00736,92226,517
Receivables10,4396,6195,98710,537  
Inventory, net of allowances, customer advances and progress billings6,8057,8704,6511,95756 
Inventory6,8057,8704,6511,95756 
Prepaid expense1,8452,1043,1821,7801,104696
Other undisclosed current assets3,3132,2475,1462,571546477
Total current assets:320,797210,106159,244111,36455,18785,187
Noncurrent Assets
Operating lease, right-of-use asset2,7703,017 793
Property, plant and equipment847959130210245191
Long-term investments and receivables    5,008 
Long-term investments    5,008 
Intangible assets, net (including goodwill)32,471     
Intangible assets, net (excluding goodwill)32,471     
Deposits noncurrent assets 999999
Deferred income tax assets18,73623,69732,971 
Total noncurrent assets:54,83327,68233,1101,0135,263200
TOTAL ASSETS:375,630237,788192,354112,37660,45085,387
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities57,58827,06322,75624,0999,5114,266
Accounts payable3,9752,7684,2564,1172,3371,946
Accrued liabilities53,61324,29518,50019,9817,1742,321
Total current liabilities:57,58827,06322,75624,0999,5114,266
Noncurrent Liabilities
Long-term debt and lease obligation:  3,894 648  
Liabilities, other than long-term debt17,621   155157
Accounts payable and accrued liabilities     155157
Other liabilities14,064     
Operating lease, liability3,5573,894 648
Other undisclosed noncurrent liabilities  (3,894)    
Total noncurrent liabilities:17,6213,894 648155157
Total liabilities:75,20930,95722,75624,7469,6664,424
Equity
Equity, attributable to parent300,421206,831169,59887,63050,78480,964
Common stock105103104103103103
Additional paid in capital250,430233,186223,168216,206211,265207,422
Accumulated other comprehensive income (loss)24(148)3110(20) 
Retained earnings (accumulated deficit)49,862(26,310)(53,706)(128,689)(160,564)(126,560)
Total equity:300,421206,831169,59887,63050,78480,964
TOTAL LIABILITIES AND EQUITY:375,630237,788192,354112,37660,45085,387

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues214,203140,833119,073102,306500 
Cost of revenue
(Cost of Goods and Services Sold)
(34,393)(21,884)(17,039)(14,759)  
Gross profit:179,810118,949102,03487,547500 
Operating expenses(77,972)(66,564)(60,730)(55,724)(35,795)(18,680)
Other undisclosed operating loss      
Operating income (loss):101,83852,38541,30331,823(35,295)(18,680)
Nonoperating income
(Other Nonoperating income)
2,8812825871,5861,292454
Income (loss) from continuing operations before equity method investments, income taxes:104,71952,66741,89033,409(34,004)(18,225)
Other undisclosed loss from continuing operations before income taxes      (187)
Income (loss) from continuing operations before income taxes:104,71952,66741,89033,409(34,004)(18,412)
Income tax expense (benefit)(21,640)(13,185)33,093(1,534)  
Income (loss) from continuing operations:83,07939,48274,98331,875(34,004)(18,412)
Income (loss) before gain (loss) on sale of properties:39,48274,98331,875(34,004)(18,412)
Net income (loss) available to common stockholders, diluted:83,07939,48274,98331,875(34,004)(18,412)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):83,07939,48274,98331,875(34,004)(18,412)
Other comprehensive income (loss)172(179)2230(20) 
Other undisclosed comprehensive income      
Comprehensive income (loss):83,25139,30375,00531,905(34,024)(18,412)
Other undisclosed comprehensive loss, net of tax, attributable to parent      
Comprehensive income (loss), net of tax, attributable to parent:83,25139,30375,00531,905(34,024)(18,412)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: